Gastric Cancer Stage Clinical Trials

3 recruiting

Gastric Cancer Stage Trials at a Glance

11 actively recruiting trials for gastric cancer stage are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in Shanghai, Hangzhou, and Jiaxing. Lead sponsors running gastric cancer stage studies include Ruijin Hospital, The First Affiliated Hospital with Nanjing Medical University, and Shanghai Minimally Invasive Surgery Center.

Browse gastric cancer stage trials by phase

Treatments under study

About Gastric Cancer Stage Clinical Trials

Looking for clinical trials for Gastric Cancer Stage? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Gastric Cancer Stage trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Gastric Cancer Stage clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 2

LM-302 and S-1 Plus Intraperitoneal Paclitaxel With or Without Cadonilimab for Claudin 18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma With Peritoneal Metastasis: a Prospective, Exploratory Study

Peritoneal Metastases From Gastric CancerGastric Cancer Stage IVGastric or Esophagogastric Junction Adenocarcinoma
Ruijin Hospital74 enrolled1 locationNCT07556640
Recruiting

Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy

Esophageal CancerGastroparesisGastric Cancer Stage
Zhejiang University5,000 enrolled3 locationsNCT07104214
Recruiting
Phase 2

HEARTS Trial for Thoracic Cancers

Non-Small Cell Lung Cancer (Stage III)Esophageal Cancer Stage I-IIIEsophagogastric Cancer Stage I-III+2 more
University of Wisconsin, Madison60 enrolled1 locationNCT07132918
Recruiting
Phase 2

Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

Peritoneal MetastasesGastric Cancer Stage IV
Ruijin Hospital40 enrolled1 locationNCT06519591
Recruiting

AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT

Gastric Cancer StageGastric Cancer Patients Undergoing Gastrectomy
The First Affiliated Hospital with Nanjing Medical University8,000 enrolled1 locationNCT07250347
Recruiting
Phase 1Phase 2

Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) Cancer

Gastric Cancer Stage IV
Yonsei University71 enrolled1 locationNCT04592211
Recruiting
Phase 3

Investigation of Impact of Indocyanine Green on Volume of Lymphadenectomy in Resectable Gastric Cancer

Gastric CancerGastrectomy for Gastric CancerGastric Cancer Stage II+1 more
Ukrainian Society of Clinical Oncology105 enrolled2 locationsNCT06755554
Recruiting
Phase 1Phase 2

Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab

Gastric Cancer Stage IV
Fujian Cancer Hospital51 enrolled1 locationNCT05319639
Recruiting

Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer

Gastric Cancer Stage
The First Affiliated Hospital with Nanjing Medical University222 enrolled1 locationNCT05508126
Recruiting
Phase 2

Exploratory Single-arm, Single-center Adjuvant Treatment of Stage IIIB-IIIC Gastric Cancer With Combination of Palizumab and SOX Regimen

Gastric Cancer Stage IIIB-IIIC
Shanghai Minimally Invasive Surgery Center20 enrolled1 locationNCT06036745
Recruiting
Not Applicable

A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer

Gastric Cancer Stage IIGastric Cancer Stage III
The Affiliated Hospital of Qingdao University588 enrolled1 locationNCT06042998